Implications of the New US Cholesterol Guidelines in the Brazilian Longitudinal Study of Adult Health (ELSA-Brasil)
- PMID: 26848714
- PMCID: PMC6490861
- DOI: 10.1002/clc.22511
Implications of the New US Cholesterol Guidelines in the Brazilian Longitudinal Study of Adult Health (ELSA-Brasil)
Abstract
Background: The new US guidelines for the primary prevention of cardiovascular disease have substantially changed the approach to hyperlipidemia treatment. However, the impact of those recommendations in other populations is limited. In the present study, we evaluated the potential implications of those recommendations in the Brazilian population.
Hypothesis: The new U.S. recommendations may increase the proportion of individuals who are candidates for statin therapy.
Methods: We included all participants of the Brazilian Longitudinal Study of Adult Health (ELSA-Brasil) without known cardiovascular disease. We calculated the indication for statin therapy according to the current Brazilian recommendations and the new US guidelines, using both the 5.0% and the 7.5% risk cutoffs to recommend treatment, and compared their impact in the Brazilian population stratified by age, sex, and race.
Results: Although the current guidelines would recommend treatment for 5499 (39.1%) individuals, the number of individuals eligible for statin therapy increased to 6014 (42.7%) and to 7130 (50.7%) using the 7.5% and 5% cutoffs, respectively (P < 0.001). This difference is more pronounced for older individuals, and virtually all individuals age >70 years would be eligible for statins, whereas the new guidelines would reduce the number of candidates for statin therapy in individuals age <45 years.
Conclusions: The application of the new US guidelines for the use of lipid-lowering medications in a large middle-aged Brazilian cohort would result in a significant increase in the population eligible for statins. This is largely driven by males and older individuals. Additional cost-effectiveness analyses are needed to define the appropriateness of this strategy in the Brazilian population.
© 2016 Wiley Periodicals, Inc.
Figures



Similar articles
-
The New 2018 Cholesterol Guidelines.Circulation. 2019 Jun 18;139(25):2805-2808. doi: 10.1161/CIRCULATIONAHA.118.038629. Epub 2018 Nov 10. Circulation. 2019. PMID: 30586686 No abstract available.
-
Increased statin eligibility based on ACC/AHA versus NCEP guidelines for high cholesterol management in Chile.J Clin Lipidol. 2016 Jan-Feb;10(1):192-8.e1. doi: 10.1016/j.jacl.2015.11.008. Epub 2015 Nov 14. J Clin Lipidol. 2016. PMID: 26892136
-
Extent of undertreatment and overtreatment with cholesterol-lowering therapy according to European guidelines in 92,348 Danes without ischemic cardiovascular disease and diabetes in 2004-2014.Atherosclerosis. 2017 Feb;257:9-15. doi: 10.1016/j.atherosclerosis.2016.11.025. Epub 2016 Nov 24. Atherosclerosis. 2017. PMID: 28038381
-
Advances in the management of hyperlipidemia-induced atherosclerosis.Expert Rev Cardiovasc Ther. 2008 Mar;6(3):369-83. doi: 10.1586/14779072.6.3.369. Expert Rev Cardiovasc Ther. 2008. PMID: 18327996 Review.
-
Management of Hypercholesterolemia, Appropriateness of Therapeutic Approaches and New Drugs in Patients with High Cardiovascular Risk.High Blood Press Cardiovasc Prev. 2016 Sep;23(3):217-30. doi: 10.1007/s40292-016-0155-2. Epub 2016 Aug 27. High Blood Press Cardiovasc Prev. 2016. PMID: 27567901 Free PMC article. Review.
Cited by
-
Cardiovascular Risk Estimates in Ten Years in the Brazilian Population, a Population-Based Study.Arq Bras Cardiol. 2021 Mar;116(3):423-431. doi: 10.36660/abc.20190861. Arq Bras Cardiol. 2021. PMID: 33909770 Free PMC article. English, Portuguese.
-
Cardiovascular Risk Stratification and Statin Eligibility Based on the Brazilian vs. North American Guidelines on Blood Cholesterol Management.Arq Bras Cardiol. 2017 Jun;108(6):508-517. doi: 10.5935/abc.20170088. Arq Bras Cardiol. 2017. PMID: 28699974 Free PMC article.
-
Guideline-based statin/lipid-lowering therapy eligibility for primary prevention and accuracy of coronary artery calcium and clinical cardiovascular events: The Multi-Ethnic Study of Atherosclerosis (MESA).Clin Cardiol. 2017 Mar;40(3):163-169. doi: 10.1002/clc.22642. Epub 2016 Nov 12. Clin Cardiol. 2017. PMID: 27859433 Free PMC article.
-
Association between soft drink consumption and cardiovascular disease risk among Brazilian adults: a cross-sectional study.Sao Paulo Med J. 2025 Aug 15;143(4):e2023433. doi: 10.1590/1516-3180.2023.0433.R1.29112024. eCollection 2025. Sao Paulo Med J. 2025. PMID: 40834162 Free PMC article.
References
-
- Sposito AC, Caramelli B, Fonseca FA, et al. IV Brazilian Guideline for Dyslipidemia and Atherosclerosis prevention: Department of Atherosclerosis of Brazilian Society of Cardiology [article in Portuguese]. Arq Bras Cardiol. 2007;88(suppl 1):2–19. - PubMed
-
- Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults . Executive Summary of the Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA. 2001;285:2486–2497. - PubMed
-
- Stone NJ, Robinson JG, Lichtenstein AH, et al; American College of Cardiology/American Heart Association Task Force on Practice Guidelines . 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines [published correction appears in Circulation. 2014;129(25 suppl 2):S46–S48]. Circulation. 2014;129(25 suppl 2):S1–S45. - PubMed
-
- Cook NR, Ridker PM. Response to Comment on the reports of over‐estimation of ASCVD risk using the 2013 AHA/ACC risk equation. Circulation. 2014;129:268–269. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical